Your browser doesn't support javascript.
loading
[Antimetabolites]. / Les antimétabolites.
Lansiaux, Amélie.
Afiliación
  • Lansiaux A; Centre Oscar-Lambret, Université Lille Nord de France. a-Lansiaux@o-lambret.fr
Bull Cancer ; 98(11): 1263-74, 2011 Nov.
Article en Fr | MEDLINE | ID: mdl-22049385
ABSTRACT
Antimetabolites are cytotoxic agents, which have been developed for more than 50  years. Which cancer patient did not receive or will not receive 5-fluorouracil or methotrexate during the evolution his or her disease? Antimetabolites are defined as interfering with the synthesis of the DNA constituents; they are structural analogues, either of purine and pyrimidine bases (or the corresponding nucleosides), or of folate cofactors, which are involved at several steps of purine and pyrimidine biosynthesis. Their first mechanism of action is, therefore, to induce depletion in nucleotides inducing in turn an inhibition of DNA replication. However, some of them are able to get inserted fraudulently into nucleic acids, inducing structural abnormalities leading to cell death by other mechanisms, including DNA breaks. We present in this paper, for the three classes of antimetabolites, both ancient and recent molecules as well as molecules still in clinical trials, without exhaustivity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Purinas / Pirimidinas / Antagonistas del Ácido Fólico / Neoplasias / Antimetabolitos Antineoplásicos Límite: Humans Idioma: Fr Revista: Bull Cancer Año: 2011 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Purinas / Pirimidinas / Antagonistas del Ácido Fólico / Neoplasias / Antimetabolitos Antineoplásicos Límite: Humans Idioma: Fr Revista: Bull Cancer Año: 2011 Tipo del documento: Article